(AIRS) Airsculpt Technologies - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0094961002
AIRS: Body Contouring, Fat Removal, Skin Tightening, Cellulite Removal
AirSculpt Technologies, Inc., operating as a holding company for EBS Intermediate Parent LLC, specializes in advanced body contouring services across the United States. Established in 2012 and headquartered in Miami Beach, Florida, the company offers a suite of minimally invasive procedures designed to address unwanted fat and skin tightening. Their flagship procedure, AirSculpt, utilizes precise technology to remove fat and tighten skin, while AirSculpt+ offers permanent fat removal with enhanced precision. Additionally, AirSculpt Smooth targets cellulite with advanced technology. The company also provides fat transfer procedures for breast, buttock, hip, and other area enhancements, including procedures like Power BBL, Up a Cup, and Hip Flip. With a focus on innovation and patient care, AirSculpt Technologies operates multiple centers, catering to a growing demand for minimally invasive aesthetic solutions.
Over the next three months, AirSculpt Technologies Inc. (NASDAQ:AIRS) is expected to face a challenging environment. Technically, the stock has broken below its 20-day and 50-day moving averages, suggesting bearish momentum. The relative strength index (RSI) is near oversold levels, indicating potential consolidation. The average true range (ATR) of 0.48 suggests moderate volatility. From a fundamental perspective, the companys negative price-to-earnings (P/E) ratio and return on equity (RoE) of -9.44% raise concerns about profitability. However, the price-to-sales (P/S) ratio of 1.39 indicates revenue generation, and the growing demand for minimally invasive aesthetic procedures could provide upside potential. Overall, the stock is likely to remain under pressure near term but could stabilize if operational efficiencies improve.
Additional Sources for AIRS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AIRS Stock Overview
Market Cap in USD | 197m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2021-10-29 |
AIRS Stock Ratings
Growth 5y | -50.3% |
Fundamental | -16.7% |
Dividend | 1.0% |
Rel. Strength Industry | -50.3 |
Analysts | 3/5 |
Fair Price Momentum | 2.22 USD |
Fair Price DCF | 0.27 USD |
AIRS Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 1.0% |
AIRS Growth Ratios
Growth Correlation 3m | -66.1% |
Growth Correlation 12m | 15.5% |
Growth Correlation 5y | -61.3% |
CAGR 5y | -38.65% |
CAGR/Max DD 5y | -0.46 |
Sharpe Ratio 12m | -0.05 |
Alpha | -67.56 |
Beta | 3.20 |
Volatility | 114.55% |
Current Volume | 454.3k |
Average Volume 20d | 128.1k |
As of March 14, 2025, the stock is trading at USD 2.94 with a total of 454,276 shares traded.
Over the past week, the price has changed by -25.19%, over one month by -51.00%, over three months by -48.24% and over the past year by -50.42%.
Neither. Based on ValueRay Fundamental Analyses, Airsculpt Technologies is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AIRS as of March 2025 is 2.22. This means that AIRS is currently overvalued and has a potential downside of -24.49%.
Airsculpt Technologies has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold AIRS.
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AIRS Airsculpt Technologies will be worth about 2.6 in March 2026. The stock is currently trading at 2.94. This means that the stock has a potential downside of -11.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.8 | 95.6% |
Analysts Target Price | 6.3 | 112.6% |
ValueRay Target Price | 2.6 | -11.2% |